Dr. Joshi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-8000Fax+1 214-645-7269
Summary
- Dr. Parag Joshi is a cardiologist in Dallas, TX and is affiliated with University of Texas Southwestern Medical Center. He received his medical degree from Texas Tech University Health Sciences Center School of Medicine and has been in practice 11 years. He specializes in cardiothoracic imaging, non-invasive cardiology, and preventive cardiology and is experienced in general cardiology, preventive cardiology, and heart failure and transplantation.
Education & Training
- Johns Hopkins UniversityFellowship, Cardiovascular Disease, 2011 - 2015
- Johns Hopkins Bloomberg School of Public HealthMHS, 2013 - 2014
- Piedmont Heart InstituteFellowship, Preventive Cardiology, 2009 - 2011
- Emory University School of MedicineResidency, Internal Medicine, 2006 - 2009
- Texas Tech University Health Sciences Center School of MedicineClass of 2006
Certifications & Licensure
- TX State Medical License 2015 - 2026
- MD State Medical License 2012 - 2016
- GA State Medical License 2009 - 2012
- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 31 citationsMultimodality Imaging of Complications of Cardiac Valve Surgeries.Prabhakar Rajiah, Alastair J. Moore, Sachin Saboo, Harold Goerne, Praveen Ranganath
Radiographics. 2019-05-31 - 41 citationsDiagnosis and Management of Stable Angina: A Review.Parag H. Joshi, James A. de Lemos
JAMA. 2021-05-04 - 14 citationsEffect of Anacetrapib on Cholesterol Efflux Capacity: A Substudy of the DEFINE Trial.Mark P. Metzinger, Suzanne Saldanha, Jaskeerat Gulati, Kershaw V. Patel, Ayea El-Ghazali
Journal of the American Heart Association. 2020-12-15
Authored Content
- ODYSSEY OutcomesJuly 2018
Press Mentions
- How Lp(A) Can Help Improve ASCVD Risk AssessmentMarch 1st, 2022
- What Can Lp(A) Add to CAC for ASCVD Risk Prediction? New InsightsFebruary 22nd, 2022
- Liraglutide Reduces Visceral, Ectopic Fat to Improve CVD OutcomesAugust 18th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: